CN104666468A - Pharmaceutical composition for treating hyperthyroidism and scrofula - Google Patents
Pharmaceutical composition for treating hyperthyroidism and scrofula Download PDFInfo
- Publication number
- CN104666468A CN104666468A CN201510125051.1A CN201510125051A CN104666468A CN 104666468 A CN104666468 A CN 104666468A CN 201510125051 A CN201510125051 A CN 201510125051A CN 104666468 A CN104666468 A CN 104666468A
- Authority
- CN
- China
- Prior art keywords
- parts
- pharmaceutical composition
- hyperthyroidism
- radix
- scrofula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010020850 Hyperthyroidism Diseases 0.000 title claims abstract description 40
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 15
- 201000007227 lymph node tuberculosis Diseases 0.000 title abstract description 9
- 239000003814 drug Substances 0.000 claims abstract description 38
- 239000002994 raw material Substances 0.000 claims abstract description 8
- 238000011282 treatment Methods 0.000 claims description 32
- 238000002360 preparation method Methods 0.000 claims description 4
- 230000000694 effects Effects 0.000 abstract description 19
- 240000007311 Commiphora myrrha Species 0.000 abstract description 3
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract description 3
- 239000004863 Frankincense Substances 0.000 abstract description 3
- 241000533849 Gleditsia Species 0.000 abstract description 3
- 241001061264 Astragalus Species 0.000 abstract description 2
- 241000202726 Bupleurum Species 0.000 abstract description 2
- 241000903946 Clematidis Species 0.000 abstract description 2
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract description 2
- 240000004534 Scutellaria baicalensis Species 0.000 abstract description 2
- 235000017089 Scutellaria baicalensis Nutrition 0.000 abstract description 2
- 235000006533 astragalus Nutrition 0.000 abstract description 2
- 210000004233 talus Anatomy 0.000 abstract description 2
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 235000003717 Boswellia sacra Nutrition 0.000 abstract 1
- 240000007551 Boswellia serrata Species 0.000 abstract 1
- 235000012035 Boswellia serrata Nutrition 0.000 abstract 1
- 241000576429 Forsythia suspensa Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 230000007547 defect Effects 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 201000008827 tuberculosis Diseases 0.000 description 17
- 208000002193 Pain Diseases 0.000 description 15
- 210000004369 blood Anatomy 0.000 description 13
- 239000008280 blood Substances 0.000 description 13
- 210000001685 thyroid gland Anatomy 0.000 description 12
- 206010007247 Carbuncle Diseases 0.000 description 11
- 210000004185 liver Anatomy 0.000 description 11
- 231100000614 poison Toxicity 0.000 description 11
- 235000009508 confectionery Nutrition 0.000 description 10
- 230000001737 promoting effect Effects 0.000 description 10
- 229940079593 drug Drugs 0.000 description 9
- 208000033809 Suppuration Diseases 0.000 description 8
- 210000000214 mouth Anatomy 0.000 description 8
- 230000001225 therapeutic effect Effects 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 206010018498 Goitre Diseases 0.000 description 7
- 208000025865 Ulcer Diseases 0.000 description 7
- 230000017531 blood circulation Effects 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 239000000796 flavoring agent Substances 0.000 description 7
- 235000019634 flavors Nutrition 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 201000003872 goiter Diseases 0.000 description 7
- XMBWDFGMSWQBCA-RNFDNDRNSA-M iodine-131(1-) Chemical compound [131I-] XMBWDFGMSWQBCA-RNFDNDRNSA-M 0.000 description 7
- 210000001165 lymph node Anatomy 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- 241000628997 Flos Species 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 239000002574 poison Substances 0.000 description 6
- 230000008961 swelling Effects 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 5
- 210000001015 abdomen Anatomy 0.000 description 5
- 230000001154 acute effect Effects 0.000 description 5
- 238000002651 drug therapy Methods 0.000 description 5
- 208000015181 infectious disease Diseases 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 239000003440 toxic substance Substances 0.000 description 5
- 231100000397 ulcer Toxicity 0.000 description 5
- 201000000736 Amenorrhea Diseases 0.000 description 4
- 206010001928 Amenorrhoea Diseases 0.000 description 4
- 208000005171 Dysmenorrhea Diseases 0.000 description 4
- 206010013935 Dysmenorrhoea Diseases 0.000 description 4
- 208000015220 Febrile disease Diseases 0.000 description 4
- 206010017553 Furuncle Diseases 0.000 description 4
- 206010020772 Hypertension Diseases 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 206010057190 Respiratory tract infections Diseases 0.000 description 4
- 231100000540 amenorrhea Toxicity 0.000 description 4
- 238000005469 granulation Methods 0.000 description 4
- 230000003179 granulation Effects 0.000 description 4
- 210000002216 heart Anatomy 0.000 description 4
- 241000411851 herbal medicine Species 0.000 description 4
- 235000008216 herbs Nutrition 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 239000002398 materia medica Substances 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 230000008736 traumatic injury Effects 0.000 description 4
- 201000010000 Agranulocytosis Diseases 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 3
- 241001608538 Boswellia Species 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- 239000009636 Huang Qi Substances 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 3
- 208000007502 anemia Diseases 0.000 description 3
- 229940043671 antithyroid preparations Drugs 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 210000003128 head Anatomy 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 210000003141 lower extremity Anatomy 0.000 description 3
- PMRYVIKBURPHAH-UHFFFAOYSA-N methimazole Chemical compound CN1C=CNC1=S PMRYVIKBURPHAH-UHFFFAOYSA-N 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 206010040872 skin infection Diseases 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 229960002178 thiamazole Drugs 0.000 description 3
- 230000002792 vascular Effects 0.000 description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 206010002383 Angina Pectoris Diseases 0.000 description 2
- 241000208173 Apiaceae Species 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 235000018062 Boswellia Nutrition 0.000 description 2
- 241000717739 Boswellia sacra Species 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- 208000003322 Coinfection Diseases 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 201000000297 Erysipelas Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010020674 Hypermetabolism Diseases 0.000 description 2
- 241000283956 Manis Species 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 240000007817 Olea europaea Species 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- QTENRWWVYAAPBI-YZTFXSNBSA-N Streptomycin sulfate Chemical compound OS(O)(=O)=O.OS(O)(=O)=O.OS(O)(=O)=O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@H]1[C@H](N=C(N)N)[C@@H](O)[C@H](N=C(N)N)[C@@H](O)[C@@H]1O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@H]1[C@H](N=C(N)N)[C@@H](O)[C@H](N=C(N)N)[C@@H](O)[C@@H]1O QTENRWWVYAAPBI-YZTFXSNBSA-N 0.000 description 2
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 238000001467 acupuncture Methods 0.000 description 2
- 230000003208 anti-thyroid effect Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 208000001936 exophthalmos Diseases 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 210000002683 foot Anatomy 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 230000002443 hepatoprotective effect Effects 0.000 description 2
- 210000003026 hypopharynx Anatomy 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 208000030208 low-grade fever Diseases 0.000 description 2
- -1 luteolin glycosides Chemical class 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 201000008383 nephritis Diseases 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 230000008093 supporting effect Effects 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- 230000008700 sympathetic activation Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 230000036269 ulceration Effects 0.000 description 2
- 201000002327 urinary tract obstruction Diseases 0.000 description 2
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 206010001580 Albuminuria Diseases 0.000 description 1
- FVVDKUPCWXUVNP-UHFFFAOYSA-M Aminosalicylate sodium anhydrous Chemical compound [Na+].NC1=CC=C(C([O-])=O)C(O)=C1 FVVDKUPCWXUVNP-UHFFFAOYSA-M 0.000 description 1
- 241000213006 Angelica dahurica Species 0.000 description 1
- 241000382455 Angelica sinensis Species 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 206010003658 Atrial Fibrillation Diseases 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 206010061695 Biliary tract infection Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 241000510654 Bupleurum chinense Species 0.000 description 1
- 241000522234 Caesalpinia Species 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 208000006029 Cardiomegaly Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241000242722 Cestoda Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 101100285402 Danio rerio eng1a gene Proteins 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 206010013700 Drug hypersensitivity Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010015993 Eyelid oedema Diseases 0.000 description 1
- 206010060710 Galactostasis Diseases 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 241000931143 Gleditsia sinensis Species 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- 206010018687 Granulocytopenia Diseases 0.000 description 1
- 208000003807 Graves Disease Diseases 0.000 description 1
- 208000003084 Graves Ophthalmopathy Diseases 0.000 description 1
- 208000015023 Graves' disease Diseases 0.000 description 1
- 241000143510 Haliotis discus hannai Species 0.000 description 1
- 241001489138 Haliotis diversicolor Species 0.000 description 1
- 241000533388 Hansenia weberbaueriana Species 0.000 description 1
- 206010067873 Hashitoxicosis Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 241000594394 Hedyotis Species 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- XUIIKFGFIJCVMT-LBPRGKRZSA-N L-thyroxine Chemical compound IC1=CC(C[C@H]([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-LBPRGKRZSA-N 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 241000283967 Manidae Species 0.000 description 1
- 241001282397 Manis pentadactyla Species 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 241001057584 Myrrha Species 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 241000283966 Pholidota <mammal> Species 0.000 description 1
- 208000007913 Pituitary Neoplasms Diseases 0.000 description 1
- 208000021738 Plummer disease Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- KNAHARQHSZJURB-UHFFFAOYSA-N Propylthiouracile Chemical compound CCCC1=CC(=O)NC(=S)N1 KNAHARQHSZJURB-UHFFFAOYSA-N 0.000 description 1
- 241000219780 Pueraria Species 0.000 description 1
- 244000046146 Pueraria lobata Species 0.000 description 1
- 235000010575 Pueraria lobata Nutrition 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 241001093501 Rutaceae Species 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 241000207929 Scutellaria Species 0.000 description 1
- 206010067868 Skin mass Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010041925 Staphylococcal infections Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 208000001871 Tachycardia Diseases 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 206010043784 Thyroiditis subacute Diseases 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 206010047115 Vasculitis Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 210000002187 accessory nerve Anatomy 0.000 description 1
- 230000004308 accommodation Effects 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 239000003200 antithyroid agent Substances 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 208000003167 cholangitis Diseases 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 239000000571 coke Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000039 congener Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 201000005311 drug allergy Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- 206010016165 failure to thrive Diseases 0.000 description 1
- 208000024756 faint Diseases 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 210000003714 granulocyte Anatomy 0.000 description 1
- 230000002650 habitual effect Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 208000003532 hypothyroidism Diseases 0.000 description 1
- 230000002989 hypothyroidism Effects 0.000 description 1
- 150000002460 imidazoles Chemical class 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000031891 intestinal absorption Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 229960003350 isoniazid Drugs 0.000 description 1
- QRXWMOHMRWLFEY-UHFFFAOYSA-N isoniazide Chemical compound NNC(=O)C1=CC=NC=C1 QRXWMOHMRWLFEY-UHFFFAOYSA-N 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 229960003918 levothyroxine sodium Drugs 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 239000010871 livestock manure Substances 0.000 description 1
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 1
- 235000009498 luteolin Nutrition 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 210000001365 lymphatic vessel Anatomy 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 230000036210 malignancy Effects 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 210000001989 nasopharynx Anatomy 0.000 description 1
- 239000011050 natural pearl Substances 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 210000002741 palatine tonsil Anatomy 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 208000010916 pituitary tumor Diseases 0.000 description 1
- 208000007884 postpartum thyroiditis Diseases 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 229960002662 propylthiouracil Drugs 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 238000006479 redox reaction Methods 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 description 1
- 229960001225 rifampicin Drugs 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 208000037921 secondary disease Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 229940046927 sodium aminosalicylate Drugs 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 208000015339 staphylococcus aureus infection Diseases 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 201000007540 subacute lymphocytic thyroiditis Diseases 0.000 description 1
- 201000007497 subacute thyroiditis Diseases 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 231100000057 systemic toxicity Toxicity 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000006794 tachycardia Effects 0.000 description 1
- ZEMGGZBWXRYJHK-UHFFFAOYSA-N thiouracil Chemical class O=C1C=CNC(=S)N1 ZEMGGZBWXRYJHK-UHFFFAOYSA-N 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000008359 toxicosis Effects 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 210000001364 upper extremity Anatomy 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 231100000925 very toxic Toxicity 0.000 description 1
- 230000009978 visual deterioration Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention discloses a pharmaceutical composition for treating hyperthyroidism and scrofula. The pharmaceutical composition is prepared from the following raw materials in parts by weight: 4-8 parts of radix angelicae lateralis preparata, 1-5 parts of stir-baked squama manitis, 1-4 parts of gleditsia thorn, 1-3 parts of forsythia suspensa, 1-3 parts of frankincense, 1-3 parts of myrrh, 1-5 parts of pollen, 5-10 parts of bupleurum sinenses, 1-3 parts of scutellaria baicalensis, 1-3 parts of pachyrhizua angulatus, 1-3 parts of radix clematidis, 1-3 parts of sapanwood, 2-7 parts of notopterygium roots, 1-3 parts of radix angelicae, 2-5 parts of honeysuckle flowers, 1-3 parts of astragalus lithophilus, 1-5 parts of radix saposhnikoviae, 1-3 parts of concha haliotidis and 1-3 parts of liquorice. The pharmaceutical composition for treating hyperthyroidism and scrofula overcomes the defect of the existing medicine for treating hyperthyroidism and scrofula, and is good in effect.
Description
Technical field
The present invention relates to technical field of Chinese medicines, be specifically related to one and treat hyperthyroidism, scrofulous pharmaceutical composition.
Background technology
Hyperthyroidism is called for short " hyperthyroidism ", is due to the too much thyroxin of thyroid synthesis release, causes the hyperfunction and sympathetic activation of organism metabolism, causes cardiopalmus, perspiration, feed and the just secondary disease increasing and lose weight.Most of patients also usually has the symptoms such as expophthalmos, blepharoedema, visual deterioration simultaneously.Thyroxin enhances metabolism, and promotes body redox reaction, and hypermetabolism needs body to increase feed; Gastrointestinal activity strengthens, and occurs just secondary increasing; Although feed increases, oxidation reaction strengthens, and human body energy consumption increases, and patients loses weight; Heat production increase performance To Be Protected from Heat perspire, there is low grade fever in few patients; Thyroxin increases stimulation sympathetic activation, clinical manifestation cardiopalmus, tachycardia, insomnia, responsive to surrounding, anxious state of mind, even anxiety.Hyperthyroidism disease is because comprising diffuse toxic goiter (also claiming Graves disease), and inflammatory hyperthyroidism (subacute thyroiditis, silent thyroiditis, postpartum thyroiditis and Hashitoxicosis), medicine cause hyperthyroidism (levothyroxine sodium and iodine cause hyperthyroidism), hCG dependency hyperthyroidism (the temporary hyperthyroidism of vomiting during pregnancy) and the hyperthyroidism of TSH of pituitary tumor.Hyperthyroid patient does not obtain appropriate therapeutic for a long time, can cause and become thin and hyperthyroid heart disease.Patient becomes thin and usually easily suffers from acute infectious disease and infect and to disable or dead.Hyperthyroid heart disease causes cardiac dilatation, arrhythmia, atrial fibrillation and heart failure, patient disability, even dead.
At present, Treatment of Hyperthyroidism has three kinds of methods, Anti-thyroid Medicine, radioiodine therapy and operative treatments.1, Anti-thyroid Medicine wide accommodation, no matter child adult, male or women, mild or serious symptom hyperthyroidism, First episode or hyperthyroidism recurrence, anemia of pregnant woman or lactating female hyperthyroidism can use Drug therapy.Antithyroid drug has two kinds---and imidazoles and thiouracil class, represent medicine and be respectively thiamazole (also known as " thiamazole ") and propylthiouracil (also known as " third is phonetic ").2, Drug therapy is applicable to the patient of Hyperthyroidism Mothers, child, thyroid silght enlargement, and treatment generally needs 1-2, needs according to thyroid function situation increase and decrease drug dose in treatment.Drug therapy has some side effect, comprise granulocytopenia, drug allergy, liver function damage, arthralgia and vasculitis, the Drug therapy initial stage needs tightly to monitor side effects of pharmaceutical drugs, especially agranulocytosis, need to warn patient once there is heating and/or pharyngalgia, need to check granulocyte immediately clearly whether there is agranulocytosis, once occur.Drug withdrawal emergency treatment immediately.Another shortcoming of Drug therapy is that after drug withdrawal, relapse rate is high, greatly about about 50%.3, radioiodine therapy and operative treatment all belong to destructive treatment, and hyperthyroidism is not easy recurrence, and treatment only needs once.Radioiodine is applicable to the patient of thyroid moderate swelling or hyperthyroidism recurrence, and doctor calculates the radiological dose of each needs of patients according to the uptake ratio of patient's thyroid to radioiodine.Radioiodine is absolute contraindication to anemia of pregnant woman and nursing women.Effect due to radioiodine has a delay action, along with the time is with examining, and the annual 3-5% of hypothyroidism incidence rate.Radioiodine therapy is not suitable for the hyperthyroid patient of thyroid eye diseas, because oculopathy may be aggravated after treatment.That operative treatment is applicable to those thyromegaly is remarkable, or strong suspicion thyroid malignancy, or thyromegaly has the tracheas suppressed person that causes dyspnea.Operation consent needs to control in normal range with medicine by thyroid function, and the preoperative oral administered compound iodine solution that also needs does Preoperative Method.
Lymphoid tuberculosis, the traditional Chinese medical science is referred to as scrofula, is the malicious block organization being embodied in flesh table, is to be condensed into by the scorchingly hot poison of expectorant of liver lung two aspect.Doctor trained in Western medicine then refers to, specializes in detoxicating virus killing thus protection blood vessel, the lymphsystem of tissue, meets with ex vivo and cannot remove the toadstool killed, condense and assemble the malignant tumor formed in flesh table organization in human body.How to grow pimple in cervical region side or bilateral, grow up gradually, superficial, push slip, without obvious tenderness, as passive protective physical fitness is low, increase gradually, skin sends out purpling, and final ulceration flowing water sample pus also discharges the cheesy pus of yellow turbid sample, and the traditional Chinese medical science is referred to as to call " lymphoid tuberculosis ".Systemic toxicity profiles symptoms such as repeatedly festering few, some patients can have low grade fever, robber, antiperspirant inappetence, become thin.
Tuberculous lymphadenitis pathogenic factor has two kinds: a kind of is that tubercule bacillus infects on oral cavity and the nasopharynx part primary tumor that especially tonsil gland causes by upper respiratory tract or with food.Tailing edge lymphatic vessel arrives the shallow deep layer lymph node of cervical region.Each position mostly is Unilateral lymph node.Get involved pharyngeal.After retransmitting sick above absorption, involved lymph nodes core still continues development and forms cold abscess or ulcer.Another kind is that after primary tuberculosis infects, in blood, tubercule bacillus enters inside neck lymph node with blood, causes the tuberculosis of cervical lymph nodes; Can also infect from waist and belly lymph, then draw and deep lymph node group secondary infection, comparatively common in lymphoid tuberculosis morbidity.
At present, treatment lymphoid tuberculosis, generally adopts western medical treatment: 1, whole body therapeutic, suitably notes nutrition and rest.Oral isoniazid 1-2, with systemic toxic symptoms or the health elsewhere person that has tuberculosis.Add sodium aminosalicylate or rifampicin or add and use streptomycin intramuscular injection.2, topical therapeutic: 1) minority is limited to, and larger, the lymph node that can promote, can consider excision.Note during operation not damaging accessory nerve; 2) form cold abscess and not yet do not wear out person, pus is taken out in feasible undermining puncture.From the normal skin inserting needle around abscess.Take out most pus as far as possible, then inject in vomica 5% different cigarette wink solution or 10% Streptomycin Solution rinse.And stay appropriate in vomica, 2 times weekly; 3) cold abscess ulceration forms ulcer or sinus tract person, as secondary infection is not obvious, feasiblely to draw together except art.Carefully knot school pathological tissues is all drawn together and remove.Wound does not add stitching, changes dressings with Streptomycin Solution; 4) cold abscess secondary pyogenic infection person.Need leading incision and drainage, after infection control, row curettage more if desired.
In prior art, all come with some shortcomings for treatment hyperthyroidism, scrofulous medicine or method, the traditional Chinese medical science is of extensive knowledge and profound scholarship, and Study of Traditional Chinese Medicine treats hyperthyroidism, lymphoid tuberculosis is necessary.
Summary of the invention
The technical problem to be solved in the present invention is the deficiency overcoming existing treatment hyperthyroidism, lymphoid tuberculosis medicine, provides one to treat hyperthyroidism, the good pharmaceutical composition of lymphoid tuberculosis effect.
In pharmaceutical composition of the present invention, the consumption of each component is that inventor draws through a large amount of practice summary, is made up of the raw material of following weight parts:
Preferably, be made up by weight of following raw materials according:
The dosage form of pharmaceutical composition of the present invention can be the medically acceptable dosage form such as capsule, pill, tablet, decoction, medicated wine, and their preparation method, supplementary product consumption are undertaken by existing common process, preferred medicated wine.
The present invention also comprises the application of aforementioned pharmaceutical compositions in preparation treatment hyperthyroidism, scrofulous medicine.
The traditional Chinese medical science is thought, many being pented up through wind heat gas poison by three Jiao, liver, gallbladder etc. of scrofula incidence forms, and Liver and kidney two, through deficiency of both QI and blood, caused by dynamic in asthenic fire, can be divided into acute, chronic two classes.Acute many because of affection due to external wind and heat, in accumulate expectorant poison and send out; Because the stagnation of QI, void are hindered and sent out more than chronic.This disease is often enraged angry strongly fragrant, and it is unsuccessful to consider, and spirit is downcast.
In the present invention:
Radix Angelicae Sinensis, the supporting root of umbelliferae angelica Angelica sinensis (Oliv.) Diels.Another name: Radix Angelicae Sinensis, Radix Angelicae Sinensis, return and must, return lower limb, slightly return lower limb.Profile, Radix Angelicae Sinensis root is slightly cylindrical, and root upper end claims " returning head ", and main root claims " returning body " or " very little body ". and supporting root claims " Radix Angelicae Sinensis " or " returning lower limb ", all titles " Radix Angelicae Sinensis ".Effectiveness: Radix Angelicae Sinensis is enriched blood and invigorated blood circulation, Radix Angelicae Sinensis body is enriched blood, and Radix Angelicae Sinensis is invigorated blood circulation.Meridian distribution of property and flavor: pungent, sweet, warm.Cure mainly: promoting blood circulation and breaking stagnation, menstruction regulating and pain relieving.Control menoxenia, dysmenorrhea, stomachache, traumatic injury, skin infection.
Stir-baked SQUAMA MANITIS, another name: big gun first first sheet hard first (Squama Manis) sheet, latin name: Squama Manitis former animal Manis pentadactyla L. English name: medical material Pangolin Scales, source: be the scute of Manidae animal Manitis.Effect: the routed carbuncle of detumescence, searches wind active, stimulating milk secretion of stimulating the menstrual flow.Cure mainly: control carbuncle skin ulcer and swell, anemofrigid-damp arthralgia, amenorrhea, galactostasis, has blood in stool.Meridian distribution of property and flavor: salty is cool.1. " not Lu ": " be slightly cold." 2. " property of medicine opinion ": " very toxic." 3. " the southern regions of the Yunnan Province book on Chinese herbal medicine ": " and cold, salty in the mouth." enter liver, stomach warp.1. " detailed outline ": " enter to faint the bright warp of yin, yang." 2. " book on Chinese herbal medicine converges and says ": " enter lunar, the JUE YIN meridian of foot.”
Fructus Gleditsia acupuncture, has another name called Spina Gleditsiae, is the dry Spina jujubae of leguminous plant Fructus Gleditsia Gleditsia sinensis Lam..There is detumescence poison holding, evacuation of pus, effect of parasite killing.Be usually used in carbuncle from the beginning of or difficulty in discharging of pus; External treatment scabies leprosy.
Lian Zhao, has another name called Fructus Forsythiae, nature and flavor: bitter, cool.1. " herbal classic ": bitter in the mouth, flat.2. " not Lu ": nontoxic.3. " medicine origin ": " curing mainly secret formula " cloud, cool in nature, bitter in the mouth.4. " detailed outline ": micro-toil.Gui Jing: enter the heart, liver, gallbladder meridian.Function cures mainly: heat clearing away, removing toxic substances, eliminating stagnation, detumescence.Control warm, erysipelas, macule, carbuncle and ulcer toxic swelling, scrofula, urine stranguria with urinary obstruction.1. " herbal classic ": main cold and heat, Mus flaccidity, scrofula, carbuncle malignant boil, goiter, stagnation of pathogenic heat.2. " not Lu ": remove tapeworm.3. " property of medicine opinion ": main tonneau five types of stranguria, urinary obstruction, except heart man exopathogenic heat.4. " Japan hanako materia medica ": logical small intestinal, evacuation of pus.Control furuncle, pain relieving, logical menstruation.5. Li Gao: loose all menses stagnation of QI gather; Detumescence.6. Wang Haogu: control deaf Hun Hun Jun Jun.
Olibanum is the resin that olive subject plant Boswellia carterii Boswellia carterii Birdw. and congener Boswellia bhaurdajiana Birdw. bark ooze out.Nature and flavor: pungent, bitter, temperature.Gui Jing: GUIXIN, liver, spleen channel.Effect: blood-activating and qi-promoting pain relieving, detumescence and promoting granulation.Cure mainly: for obstruction of qi in the chest and cardialgia, gastralgia, dysmenorrhea amenorrhea, postpartum stagnation, lump in the abdomen is suffered from abdominal pain, rheumatic arthralgia, the contracture of muscle arteries and veins, traumatic injury, carbuncle skin infection.
Myrrha (Commiphora myrrha Eng1.), has another name called myrrh, is olive subject plant Herba Violae tree or the dry resin of Ha Didingshu.Main product is in African Somalia, Ethiopia and India and other places.Gather the white oleo-gum-resin of being oozed out by bark crack, in air, become rufous and hard nahlock.After smashing, fry to coke black and apply.Cure mainly breast abdomen stasis of blood pain, dysmenorrhea, amenorrhea, lump in the abdomen, traumatic injury, carbuncle skin infection, acute appendicitis, conjunctival congestion and swelling pain.There is the effect such as promoting blood circulation and stopping pain, detumescence and promoting granulation.
Pollen, can nervous system regulation, hypnotic, health invigorating; Improve gastrointestinal function, facilitating digestion, appetite strengthening, control habitual constipation; Hepatoprotective, prevents and treats anemia, diabetes, prostate hyperplasia, cardiovascular and cerebrovascular disease; Endocrine regulation, improves body function; Treatment chronic bronchitis and mucosa disease etc.
Radix Bupleuri, another name: Asia puecon Hu, Radix Bupleuri, hard Radix Bupleuri, latin name: Bupleurumchinense, section's name: Umbelliferae, generic name: Bupleurum, morphological characteristic: root manure is thick, coniform.Stem is upright, bending in "the" shape.Leaf alternate, wire lanceolar or drape over one's shoulders pin Long Circle, the long point of tip.Umbel.Spend little, yellow.Fruit ellipticity is avette.The florescence 7-8 month.Adaptable area: originate in China, be mainly distributed in the provinces such as Jilin, Liaoning, Hebei, Henan, Shandong.Also there are distribution in Korea, Japan, the Soviet Union.Habit: Chang Yesheng is unoccupied place, thick grass and roadside in drier hillside, border, woods.Like warm, moistening.Cold-resistant, drought-enduring.Water funk leaching.Well-grown in sandy loam or leaf mould, on saline-alkali soil, Failure to thrive is contained, and crispaturaing easily appears in blade.Medical value: root, stem are used as medicine, name Radix Bupleuri, can induce sweat and inner, yang invigorating, dispersing the stagnated live-QI to relieve the stagnation of QI.Be used as medicine with root.Property bitter, be slightly cold, to liver, lung have induce sweat and in, the regulating menoxenia of yang invigorating, the soothing the liver solution stasis of blood.Cure mainly flu, upper respiratory tract infection, malaria, alternate attack of chill and fever, costalgia, hepatitis, biliary tract infection, cholecystitis, menstruation are not withered, proctoptosis.
Radix Scutellariae (Classification system: Scutellaria baicalensis Georgi), another name Radix Scutellariae, tsuchikane tea root are Labiatae Scutellaria herbaceos perennials.The root of Radix Scutellariae is used as medicine, bitter in the mouth, cold in nature, has heat clearing and damp drying, eliminating fire and detoxication, hemostasis, the effect such as antiabortive.Cure mainly the diseases such as epidemic febrile disease, upper respiratory tract infection, cough due to lung-heat, damp and hot jaundice, pneumonia, dysentery, hemoptysis, conjunctival congestion, frequent fetal movement, hypertension, carbuncle furuncle.The clinical antibiotic property of Radix Scutellariae is better than Rhizoma Coptidis, and does not develop immunity to drugs.
Pachyrhizua angulatus is pulse family, the mutation (Classification system: Pueraria lobata (Willd.) Ohwi var.thomsonii (Benth.) Vaniot der Maesen) of Pueraria Pueraria lobota, cure mainly fever caused by exogenous pathogens, rigidity pain on the head and nape, measles from the beginning of, rash go out smooth, epidemic febrile disease is thirsty, quench one's thirst, have loose bowels, dysentery, hypertension, coronary heart disease.
Radix Clematidis, expelling wind and removing dampness; Promoting blood circulation to remove obstruction in the collateral; Detoxicating and resolving stagnation of pathogens.
Lignum Sappan is the dry duramen of Caesalpiniaceae Caesalpinia plant Lignum Sappan.Nature and flavor: sweet; Salty; Xin Liang.Gui Jing: the heart; Liver; Stomach; Spleen channel.Drug effect: blood circulation promoting and blood stasis dispelling, subduing swelling and relieving pain.As married woman's amenorrhea due to stagnation of blood, dysmenorrhea, postpartum stagnation cardiac and abdominal pain, puerperal blood faints, carbuncle, traumatic injury, tetanus.
Rhizoma Et Radix Notopterygii, another name Qiang is blue or green, protect Qiang envoy, recklessly king envoy, Qiang is sliding, move back wind envoy, black powder, Latin literary fame Notopterygium incisum. Umbelliferae, Notopterygium plant, perennial herb, high 60-120 centimetre, and rhizome is sturdy, extends in Bamboo-shaped.There is withered sheath in collar portion.Stem is upright, and cylindrical, hollow, has vertical straight stria, band purple.Chinese medicine cures mainly: warm in nature, dispelling cold and dampness, for affection of exogenous wind-cold, have a headache lossless, cold-damp numbness, upper limb rheumatalgia.
The Radix Angelicae Dahuricae, Latin literary fame: Angelica dahurica (Fisch.ex Hoffm.) Benth.et Hook.f.ex Franch.et Sav, perennial tall and big draft, high 1-2.5 rice, root is cylindrical, basal part of stem footpath 2-5 centimetre, a basal leaf pinnation, universal umbel top is raw or side is raw, and fruit Long Circle is to oval.Be used as medicine with root, the functions such as the dehumidifying that gets rid of illness, evacuation of pus granulation promoting, promoting blood circulation and stopping pain.Cure mainly anemofrigid cold, headache, rhinitis, toothache.The diseases such as leucorrhea with red and white discharge, pain furuncle and phyma poison, also can make spice.
Flos Lonicerae, have another name called Radix Ophiopogonis, Flos Lonicerae, Flos Lonicerae etc., cold in nature, sweet in the mouth, enters lung, the heart, stomach warp, is described as the good medicine of heat-clearing and toxic substances removing from ancient times.Its property sweet cold fragrance, clearing away heat with drugs sweet in flavor and cold in nature and not injuring one's stomach, fragrance thoroughly reaches and can be eliminating evil.Flos Lonicerae can dispelling wind-heat, also kind removing summer-heat blood poison, for various febrile disease, as fever of the body, dermexanthesis, sends out the cards such as speckle, pyretic toxicity carbuncle sore, laryngopharynx swelling and pain, equal Be very effective.Effect is summarized: heat-clearing and toxic substances removing, wind-heat dissipating.For carbuncle furuncle, sore throat, erysipelas, warm blood fulminant dysentery, anemopyretic cold, epidemic febrile disease is generated heat.Modern study proves, Flos Lonicerae contains the pharmacological component such as chlorogenic acid, luteolin glycosides, stronger restraint is had to the various pathogens such as Hemolytic streptococcus, staphylococcus aureus and upper respiratory tract infection Causative virus etc., in addition also can enhancing immunity, antiearly pregnancy, hepatoprotective, antitumor, antiinflammatory, antipyretic, hemostasis (blood coagulation), suppress intestinal absorption cholesterol etc., its clinical application widely, can be used for the treatment of respiratory tract infection, bacillary dysentery, acute urinary, hypertension etc. more than 40 with other medicines compatibility and plant disease.
Raw over sixty years of age, having another name called Radix Astragali, is the root of leguminous plant Radix Astagali or Radix Astragali.Main product is in the Inner Mongol of China, Shanxi, Heilungkiang and other places.Spring and autumn is excavated, and removing several, fibrous root head, dries, section, raw use.The root of the Radix Astragali is famous Chinese medicine.Genus Astragalus of Local Used Commercial Huang is cylindrical, slightly distortion, long 20-60 centimetre, with bar slightly long, wrinkle is few, matter is hard and continuous, mealiness foot, the sweet person of taste as well.Containing coumarin, flavone compound, Saponin and micro-folic acid and several vitamin etc.Sweet in the mouth, tepor, has invigorating QI to consolidate the body surface resistance, and effect of holder skin ulcer granulation promoting, diuretic, cures mainly the diseases such as deficient qi and blood, spontaneous perspiration, chronic diarrhea proctoptosis, uterine prolapse, nephritis edema, albuminuria, diabetes, chronic ulcer.Clinical treatment hypertension and the acute and chronic nephritis of being used for.
Radix Saposhnikoviae, another name copper rues, Hui Yun, return grass, Rhizoma Cibotii, hundred kinds, herbaceos perennial, the nice and cool weather of its happiness, resists cold, drought-resistant, main product in Hebei, Heilungkiang, Sichuan, the ground such as Inner Mongol.The Gen Kesheng of Radix Saposhnikoviae uses.Acrid in the mouth, sweet, slightly warm in nature.There is expelling pathogenic wind from the body surface, removing dampness to relieve pain, effect of relieving convulsion.
Concha Haliotidis is the shell of Bao Ke animal Haliotis diversicolor, haliotis discus hannai Ino, ear Bao, sheep Bao etc.Have another name called natural pearls mother (Lei Gong's Treatise on Preparation and Broiling of Materia Medica), Carnis Haliotidis first (Collective Notes to the Canon of Materia medica), nine hole spiral shells (" Japan hanako materia medica "), Herba Senecionis Scandentis (" detailed outline "), very sea certainly, extra large Semen Cassiae, CONCHA HALIOTIDI, abalone shells, nine hole Concha Haliotidis (" pharmacognosy "), Carnis Haliotidis skin (" Shandong Chinese medicine handbook "), golden Carnis Mactrae skin (" Shandong Chinese herbal medicine ").There is calming liver and clearing heat, effect of improving eyesight removing nebula.
Radix Glycyrrhizae, has another name called Herba Hedyotis cantonensis root, Radix Glycyrrhizae, Radix Glycyrrhizae, Radix Glycyrrhizae, and be a kind of tonification Chinese herbal medicine, medicinal part is root and rhizome, and Medicinal Materials Characters root is cylindrical, long 25-100cm, diameter 0.6-3.5cm.Crust degree of tightness differs, the brown or taupe brown of surface red.Rhizome is cylindrical, and there is bud trace on surface, has marrow in the middle part of section.Feeble QI, taste is sweet and special.Nature and flavor: sweet are flat.Gui Jing: GUIXIN warp, lung meridian, spleen channel, stomach warp.Function: QI invigorating invigorating middle warmer, heat-clearing and toxic substances removing, expelling phlegm for arresting cough, relieving spasm to stop pain, the mediation property of medicine.Cure mainly: cure mainly deficiency-weakness of spleen-QI, fatigue and weakness, shortness of breath and palpitation, cough with copious phlegm, the anxious pain of gastral cavity abdomen, extremity contraction, pathopyretic ulcer, laryngopharynx swelling and pain, medicine, alimentary toxicosis; Mitigation medicine is strong, toxicity.
In present composition side, pollen, Lian Zhao, Fructus Gleditsia acupuncture, Olibanum, life energy over sixty years of age YIN nourishing and the production of body fluid promoting, help and reduce phlegm with clearing away heat-fire with Radix Angelicae Sinensis, Squama Manis, Radix Scutellariae, north Hu, Flos Lonicerae etc., assistant with Lignum Sappan, Concha Haliotidis, Radix Saposhnikoviae with removing liver heat and toxic substances, be beneficial to improving eyesight, all medicines share, both can replenishing YIN and removing heat, again can dissipating phlegm and resolving masses, the property of medicine is regulated with Radix Glycyrrhizae, adjustable with drug effect with wine, the effect of reinforcement and elimination in combination, YIN and YANG balance regulating can be played.
Detailed description of the invention
With specific embodiment, the invention will be further described below, but the present invention is not limited to these embodiments.
Embodiment 1
Take above each raw material by proportional quantity, decoct with water twice, first time adds 7 times of water gagings, decoct 1.5 hours, second time adds 8 times of water gagings, decocts 1.5 hours, collecting decoction, filter, filtrate is concentrated into the extractum that relative density is 1.30 (surveying when 70 DEG C), adds the dextrin adjuvant of conventional amount used, technique routinely, make capsule, 0.5g/ grain.
Embodiment 2
Above each raw material is taken by proportional quantity, decoct with water twice, first time adds 7 times of water gagings, decocts 1.5 hours, and second time adds 8 times of water gagings, decoct 1.5 hours, collecting decoction, filters, and filtrate is concentrated into the extractum that relative density is 1.30 (surveying when 70 DEG C), add appropriate cane sugar powder, technique makes granule routinely.
Embodiment 3
Take above each raw material, the wine adding same weight decocts, and obtains 10 doses.
Experimental example: the embodiment of the present invention 3 treats hyperthyroidism, lymphoid tuberculosis clinical observation on the therapeutic effect:
One, hyperthyroidism clinical data is treated:
Case selection: fetch the 72 routine hyperthyroid patients coming from the court outpatient, male 32 people, female 40 people; Age 23-44 year, average 30.5 years old.72 routine patients are divided into treatment by Chinese herbs group and western medicine group at random, treatment by Chinese herbs group 36 people, male 12 people, female 20 people; Western medicine group 36 people, male 12 people, female 20 people.
Diagnostic criteria: according to " internal medicine " the 7th edition teaching material.Have hypermetabolism sings and symptoms, thyromegaly, thyroid function checks that serum T T4, FT4, TT3, FT3 increase and TSH lowers.Or have stickiness edema before exophthalmos, shin.
Therapeutic Method:
Treatment by Chinese herbs group: take medicated wine prepared by the embodiment of the present invention 3, every day 1 dose 10 days is 1 course for the treatment of.
Western medicine group: oral thiamazole sheet, every day 3 times, each 2 30 days is 1 course for the treatment of.
The standard of curative effect evaluation:
Recovery from illness: a. transference cure, body weight increases, and pulse frequency is normal, and region thyreoidea trembles and vascular murmur disappears, and goiter and exophthalmos alleviate; B. serum T 3, T4, FT4 level is normal, thyroid tablet or the T3 inhibition test positive (can suppress), and thyroid immunologic test is normal;
Effective: a. symptom takes a turn for the better, and pulse frequency slows down, and goiter is reduced, and vascular murmur alleviates; B. serum T 4, T3, FT4 level is normal, and thyroid tablet or T3 inhibition test feminine gender (can not suppress), still need continual cure.
Invalid: a. symptom is without improvement, and pulse frequency change is little, goiter is almost without reducing or becoming large, and vascular murmur is without alleviating; B. serum T 4, T3, FT4 level is still abnormal, thyroid tablet or T3 inhibition test feminine gender (can not suppress).
Therapeutic outcome:
Table 1 liang group Clinical efficacy comparison
| Number of cases | Recovery from illness | Effectively | Invalid | Effective percentage | |
| Treatment group | 36 | 24 | 8 | 0 | 100％ |
| Matched group | 36 | 6 | 22 | 8 | 77.78％ |
As can be seen from Table 1, adopt treatment by Chinese herbs hyperthyroidism of the present invention, relative to Western medicine on therapeutic effect, there is significant improvement.Chinese medicine provided by the invention have rapid-action, effective percentage is high, determined curative effect, safety are high, the advantage that has no side effect; Clinical Follow-up is without recurrence.
Two, lymphoid tuberculosis clinical data is treated:
Case selection: fetch the 48 routine hyperthyroid patients coming from the court outpatient, male 14 people, female 34 people; Age 13-32 year, average 28.6 years old.
Take medicated wine prepared by the embodiment of the present invention 3, every day 1 dose 10 days is 1 course for the treatment of.
Criterion of therapeutical effect:
Recovery from illness: transference cure;
Effective: symptom makes moderate progress, focus is improved substantially;
Invalid: without significant change or deterioration before and after treatment.
Therapeutic effect statistics is as follows:
| Number of cases | Recovery from illness | Effectively | Invalid | Effective percentage | |
| Treatment group | 48 | 35 | 13 | 0 | 100％ |
The effect that prescription of the present invention has short treating period for treatment hyperthyroidism, lymphoid tuberculosis, effects a radical cure, has no side effect.
Claims (3)
1. treat hyperthyroidism, a scrofulous pharmaceutical composition, it is characterized in that: this pharmaceutical composition is made up of the raw material of following weight parts:
2. treatment hyperthyroidism according to claim 1, scrofulous pharmaceutical composition, is characterized in that: this pharmaceutical composition is made up of the raw material of following weight parts:
3. the application of the pharmaceutical composition according to any one of claim 1-2 in preparation treatment hyperthyroidism, scrofulous medicine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510125051.1A CN104666468A (en) | 2015-03-20 | 2015-03-20 | Pharmaceutical composition for treating hyperthyroidism and scrofula |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510125051.1A CN104666468A (en) | 2015-03-20 | 2015-03-20 | Pharmaceutical composition for treating hyperthyroidism and scrofula |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104666468A true CN104666468A (en) | 2015-06-03 |
Family
ID=53302404
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510125051.1A Pending CN104666468A (en) | 2015-03-20 | 2015-03-20 | Pharmaceutical composition for treating hyperthyroidism and scrofula |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104666468A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108542933A (en) * | 2018-06-05 | 2018-09-18 | 王福珍 | A kind of antibacterial anti-inflammatory Chinese medicine composition and preparation method thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1686164A (en) * | 2005-05-08 | 2005-10-26 | 林宗禹 | Treparation method of medicine for treating thyreoidism, scrofula and hypodermic tumour and application |
-
2015
- 2015-03-20 CN CN201510125051.1A patent/CN104666468A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1686164A (en) * | 2005-05-08 | 2005-10-26 | 林宗禹 | Treparation method of medicine for treating thyreoidism, scrofula and hypodermic tumour and application |
Non-Patent Citations (2)
| Title |
|---|
| 吴彦麒等: "李赛美教授辨治甲状腺机能亢进临床经验探讨", 《全国第二十次仲景学说学术年会论文集》 * |
| 王俊槐等: "四逆散法临证经验", 《湖北中医学院学报》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108542933A (en) * | 2018-06-05 | 2018-09-18 | 王福珍 | A kind of antibacterial anti-inflammatory Chinese medicine composition and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103520572B (en) | A kind of Chinese medicine composition being used for the treatment of atopic dermatitis and preparation method thereof | |
| CN102178804B (en) | Chinese medicinal composition for treating perianal eczema and preparation method thereof | |
| CN103041256B (en) | Chinese herb preparation for curing recurrent respiratory tract infection of children | |
| CN104825914A (en) | Traditional Chinese medicinal preparation for assisted treatment of breast cancer | |
| CN103301267A (en) | Traditional Chinese medicine composition for treating hypertension and/or atherosclerosis and application thereof | |
| CN103041257B (en) | Chinese materia medica preparation for curing high fever and respiratory tract infection of children | |
| CN102846824B (en) | Traditional Chinese medicinal composition for treating cold dampness blood stasis blocking channel type diabetic feet, and its preparation method | |
| CN102178781B (en) | Chinese medicine composition for treating scrotum eczema and preparation method thereof | |
| CN104815037A (en) | Drug for treating rheumatism accumulated toxin type chronic eczema and preparation method of drug | |
| CN103463449A (en) | Traditional Chinese medicine composite used for treating haemorrhoids and preparation method and application thereof | |
| CN103007145B (en) | Traditional Chinese medicine composition for treating children rotavirus enteritis and preparation method of composition | |
| CN105435197A (en) | Pharmaceutical composition for treating chronic lymphocytic thyroiditis and preparation method thereof | |
| CN104666468A (en) | Pharmaceutical composition for treating hyperthyroidism and scrofula | |
| CN104887950A (en) | Mastitis treatment traditional Chinese medicine compound | |
| CN103041258B (en) | Chinese materia medica preparation for curing respiratory tract infection with poor appetite of children | |
| CN105770760A (en) | Preparation for treating gastric ulcer and preparation method thereof | |
| CN105998979A (en) | Traditional Chinese medicine composition for treating lung-and-kidney-yin-deficiency-type chronic pharyngitis and method | |
| CN106039075A (en) | Traditional Chinese medicine composition and method for treating lung and stomach heat accumulated type chronic pharyngitis | |
| CN105663838A (en) | Traditional Chinese medicine for treating choledocholithiasis by combining epidural anesthesia and preparation method | |
| CN104800573A (en) | Chinese medicinal composition for treating liver cancer and preparation method thereof | |
| CN105998512A (en) | Pharmaceutical composition for the treatment of femoral shaft fracture and preparation method thereof | |
| CN105412679A (en) | Traditional Chinese medicine preparation for treating lung abscess and preparation method thereof | |
| CN104707003B (en) | The Chinese medicinal capsule for the treatment of hypertension, hyperlipidemia | |
| CN104922595A (en) | Traditional Chinese medicinal preparation for herpes zoster and preparation method thereof | |
| CN103041259B (en) | Chinese materia medica preparation for curing excessive phlegm, cough and respiratory tract infection of children |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150603 |